Atelocollagen-mediated Systemic Delivery Prevents Immunostimulatory Adverse Effects of siRNA in Mammals
Open Access
- 1 February 2012
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 20 (2), 356-366
- https://doi.org/10.1038/mt.2011.221
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (17016030)
- Japan Society for the Promotion of Science (17790185, 19590273, 21590305)
This publication has 44 references indexed in Scilit:
- Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivoBiochemical and Biophysical Research Communications, 2010
- Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle GenesMolecular Therapy, 2010
- Short-hairpin RNAs delivered by lentiviral vector transduction trigger RIG-I-mediated IFN activationNucleic Acids Research, 2009
- Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon–independent apoptosis in human melanoma cellsJournal of Clinical Investigation, 2009
- The promises and pitfalls of RNA-interference-based therapeuticsNature, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Interferon-inducible antiviral effectorsNature Reviews Immunology, 2008
- Suppression of immunostimulatory siRNA-driven innate immune activation by 2′-modified RNAsBiochemical and Biophysical Research Communications, 2007
- Endo180 Binds to the C-terminal Region of Type I CollagenPublished by Elsevier ,2005
- Induction of an interferon response by RNAi vectors in mammalian cellsNature Genetics, 2003